![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Development of a Recombinant Omicron BA .1 Subunit Vaccine Candidate in Pichia pastoris
Sibel Kalyoncu, Dogu Sayili, Ayça Zeybek Kuyucu, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Sibel Kalyoncu, Dogu Sayili, Ayça Zeybek Kuyucu, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Cheryl Chong, Liang En Wee, Xuan Jin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1190-1196
Closed Access | Times Cited: 4
Cheryl Chong, Liang En Wee, Xuan Jin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1190-1196
Closed Access | Times Cited: 4
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants
Holly A. Fryer, Daryl Geers, Lennert Gommers, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106246-106246
Open Access | Times Cited: 1
Holly A. Fryer, Daryl Geers, Lennert Gommers, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106246-106246
Open Access | Times Cited: 1
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands
Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, et al.
AIDS (2024) Vol. 38, Iss. 9, pp. 1355-1365
Open Access
Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, et al.
AIDS (2024) Vol. 38, Iss. 9, pp. 1355-1365
Open Access
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity
Milja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Milja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
Dongrong Yi, Yongxin Zhang, Jing Wang, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Dongrong Yi, Yongxin Zhang, Jing Wang, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access